drugset / Trial / NCT05970822
Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML
NaSingle-groupOpen-labelTreatment
Summary
The study is to evaluate safety, pharmacokinetics, pharmacodynamics and efficacy of BC3402 in combination with azacitidine (AZA) in subjects with Myelodysplastic Syndrome (MDS) and Chronic myelomonocytic leukemia (CMML)
Timeline
- Start
- 2023-06-18
- Primary completion
- 2025-03
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BC3402 | Monoclonal antibody | — | Intravenous |
| Background | Azacitidine | Other / unclassified | — | — |